Intraocular breast metastasis: a case report

Stephen Joseph Garcia, Ronald Gonin Paraan, Corazon Ngelangel

Abstract


Breast cancer accounts for approximately 16% of all newly diagnosed cancer cases in the Philippines. Among these, 5% are metastatic at presentation. The eye is an atypical location for metastatic spread from breast cancer. A 53-year-old Filipino female presented with a breast mass with concomitant blurring of vision. Further work-up showed invasive ductal carcinoma with bone metastasis. Ophthalmologic examination showed an intraocular mass with associated exudation and retinal detachment, which explained the blurring of vision. Chemotherapy for the breast cancer subsequently reduced tumor mass of both breast and eye, with progression of both after first line chemotherapy. Clinicians should be wary of patients presenting with a known primary mass lesion with associated ophthalmologic complaints. The possibility of metastatic disease in these patients should warrant ophthalmologic screening to possibly prevent the deterioration of the quality of life of these patients.

Keywords


Intraocular mass, Metastatic breast cancer, Breast cancer

References


Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2014. [Retrieved on August 1, 2016] Available at http://globocan.iarc.fr

Philippine Breast Cancer Network- Editorial Board. Philippine Breast Cancer Network homepage. [Retrieved on August 1, 2016] Available at http://www.pbcn.org/index.html

Ngelangel CA, Wang EH. Cancer and the Philippine Cancer Control Program. Jpn J Clin Oncol. 2002;32(1): S52-S61.

Cancer.Net Editorial Board. Breast Cancer – Statistics. [Internet]. American Society of Clinical Oncology (ASCO) - Cancer.Net. [Retrieved on August 1, 2016] Available at https://www.cancer.net/cancer-types/breast-cancer/statistics

De Vita VT, Lawrence TS, Rosenberg SA. Cancer: Principle and Practice of Oncology. 10th ed. Philadelphia: Wolters Kluwer Health; 2015.

Cohen VML. Ocular Metastases. Eye (Lond). 2013;27(2):137-41.

Georgalas I, Paraskevopoulos T, Koutsandrea C, et al. Ophthalmic metastasis of breast cancer and ocular side effects from breast cancer treatment and management: mini review. Biomed Res Int. 2015;2015:574086.

Freedman MI, Folk JC. Metastatic tumors to the eye and orbit. Patient survival and clinical characteristics. Arch Ophthalmol. 1987;105(9):1215-9.

VML Cohen. Ocular metastases. Eye (Lond). 2013;27(2):137-41.

Say EA, Mercado GJ. Screening for intraocular metastases in patients with breast carcinoma. Philipp J Ophthalmol. 2009;34(1):4-7.

Parrozzani R, Frizziero L, Testi I, et al. Intraocular metastases secondary to breast carcinoma correlates with upregulation of estrogen and progesterone receptor expression in the primary tumor. Invest Ophthalmol Vis Sci. 2016;57(10):3944-8.

Singh AD, Biscotti CV. Fine needle aspiration biopsy of ophthalmic tumors. Saudi J Ophthalmol. 2012;26(2):117-23.

Parrozzani R, Frizziero L, Testi I, et al. Intraocular metastases secondary to breast carcinoma correlates with upregulation of estrogen and progesterone receptor expression in the primary tumor. Invest Ophthalmol Vis Sci. 2016;57(10):3944-8.

Ratanatharathorn V1, Powers WE, Grimm J, et al. Eye metastasis from carcinoma of the breast: diagnosis, radiation treatment and results. Cancer Treat Rev. 1991;18(4):261-76.

Georgalas I, Paraskevopoulos T, Koutsandrea C, et al. Ophthalmic metastasis of breast cancer and ocular side effects from breast cancer treatment and management: mini review. Biomed Res Int. 2015;2015:574086.




DOI: http://dx.doi.org/10.14319/ijcto.61.5

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.

------------------------------------------------------------

International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)

© International Journal of Cancer Therapy and Oncology (IJCTO)

To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.

------------------------------------------------------------

Number of visits since October, 2013
AmazingCounters.com